Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 7, 2021; 27(21): 2834-2849
Published online Jun 7, 2021. doi: 10.3748/wjg.v27.i21.2834
Published online Jun 7, 2021. doi: 10.3748/wjg.v27.i21.2834
Figure 5 Therapeutic fecal microbiota transplantation modulates T cell phenotypes.
A: Differentially expressed genes between control, dextran sodium sulphate (DSS) and fecal microbiota transplantation (FMT) group analyzed in Metascape; B: Colonic CD4+ and CD8+ T cells in DSS and FMT group; n = 4 mice per group; C: Bar charts of the percentage of T cells (bP < 0.01). CON: Control.
- Citation: Wen X, Wang HG, Zhang MN, Zhang MH, Wang H, Yang XZ. Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation. World J Gastroenterol 2021; 27(21): 2834-2849
- URL: https://www.wjgnet.com/1007-9327/full/v27/i21/2834.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i21.2834